Thursday, 29 January 2015

AstraZeneca bets on gene editing for broad range of new drugs

LONDON (Reuters) - AstraZeneca said on Thursday it had struck four research collaborations in the hot area of genome editing as it bets on a new technology to deliver better and more precise drugs for a range of diseases.
































via Reuters: Health News Read More Here..


Lake forest health and fitness http://ift.tt/1A0Qvoi

No comments:

Post a Comment